<< Back To Search

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

Notify the Multiple Myeloma Research Foundation You Are Interested In This Trial


Third Opinion Trial Synopsis:
Doctors are doing a study on a drug called budesonide for people with a type of cancer called multiple myeloma. The study will involve giving the drug to some people and giving a pretend medicine to others (to see if the real drug works). They will also test the drug on 20 people to make sure it is safe before giving it to more people.
*Third Opinion AI Generated Synopsis

Trial Summary
A randomized placebo controlled, phase 2 study of budesonide in subjects with multiple myeloma undergoing autologous stem cell transplant (ACST). The study includes a run-in period with 20 patients.

Locations & Contact

Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Is There Anything Else You Would Like To Share?